Terms and Conditions

What’s in these terms?

These terms tell you the rules for using our website https://www.recordatirarediseases.co.uk (our site).

 

Who we are

https://www.recordatirarediseases.co.uk is a site operated by registered in England and Wales under company number 9329429 with our registered office at Breakspear Park, Breakspear Way, Hemel Hempstead, Hertfordshire, HP2 4TZ, our VAT number is 203 0183 71 and Recordati Rare Diseases UK Ltd registered in England and Wales under company number 03216698 with our registered office at Greengarth, Thicket Grove, Maidenhead, Berkshire, England, SL6 4LW, our VAT number is 604178359, collectively referred to as “We” or “Recordati”.

 

We are a limited company.

 

Acceptance of these terms

By accessing and using our site, you understand that this site is subject to the following terms and conditions and you confirm that you accept without limitation or qualification these terms of use and that you agree to comply with them.

 

If you do not agree to these terms, you must not use our site.

 

We recommend that you print a copy of these terms for future reference.

 

How you may use material on our site

We are the owner or the licensee of all intellectual property rights in our site, and in the material published on it.  Those works are protected by copyright laws and treaties around the world. All such rights are reserved.

 

You may print off one copy, and may download extracts, of any page(s) from our site for your personal use and you may draw the attention of others within your organisation to content posted on our site.

 

You must not modify the paper or digital copies of any materials you have printed off or downloaded in any way, and you must not use any illustrations, photographs, video or audio sequences or any graphics separately from any accompanying text.

 

We neither warrant nor represent that your use of materials displayed on the site will not infringe rights of third parties not owned by or affiliated with Recordati.

 

Our status (and that of any identified contributors) as the authors of content on our site must always be acknowledged.

 

You must not distribute, modify, transmit, reuse, repost, use any part of the content on our site for commercial purposes without obtaining a licence to do so from us or our licensors.

 

If you print off, copy or download any part of our site in breach of these terms of use, your right to use our site will cease immediately and you must, at our option, return or destroy any copies of the materials you have made.

 

Do not rely on information on this site

The content on our site is provided for general information only. It is not intended to amount to advice on which you should rely. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

 

Although we make reasonable efforts to update the information on our site, we make no representations, warranties or guarantees, whether express or implied, that the content on our site is accurate, complete or up to date.

 

Any medical information on this site is not intended as a substitute for informed medical advice and we cannot answer unsolicited emails relating to personal healthcare issues. Information on the products mentioned on this site may vary by country. Patients and healthcare professionals should check with local medical resources and regulatory authorities for information appropriate to their country. You must consult a suitably qualified healthcare professional on any specific problem or matter which is covered by any information on this site before taking any action. Should you have a medical condition or disease, please seek advice from your own medical doctor or healthcare provider. We do not offer personalised medical diagnosis/treatment or advice.

 

We are not responsible for websites we link to

Where our site contains links to other sites and resources provided by third parties, these links are provided for your information only. Such links should not be interpreted as approval by us of those linked websites or information you may obtain from them.

 

We have no control over the contents of those sites or resources.

Our responsibility for loss or damage suffered by you

The content of this site does not constitute an invitation or offer to invest or deal in the securities.

 

We do not exclude or limit in any way our liability to you where it would be unlawful to do so. This includes liability for death or personal injury caused by our negligence or the negligence of our employees, agents or subcontractors and for fraud or fraudulent misrepresentation.

 

We exclude all implied conditions, warranties, representations or other terms that may apply to our site or any content on it.

 

We will not be liable to you for any loss or damage, whether in contract, tort (including negligence), breach of statutory duty, or otherwise, even if foreseeable, arising under or in connection with:

  • use of, or inability to use, our site; or
  • use of or reliance on any content displayed on our site.

In particular, we will not be liable for:

  • loss of profits, sales, business, or revenue;
  • business interruption;
  • loss of anticipated savings;
  • loss of business opportunity, goodwill or reputation; or
  • any indirect or consequential loss or damage.
We are not responsible for viruses and you must not introduce them

We do not guarantee that our site will be secure or free from bugs or viruses.

 

You are responsible for configuring your information technology, computer programmes and platform to access our site. You should use your own virus protection software.

 

You must not misuse our site by knowingly introducing viruses, trojans, worms, logic bombs or other material that is malicious or technologically harmful. You must not attempt to gain unauthorised access to our site, the server on which our site is stored or any server, computer or database connected to our site. You must not attack our site via a denial-of-service attack or a distributed denial-of service attack. By breaching this provision, you would commit a criminal offence under the Computer Misuse Act 1990. We will report any such breach to the relevant law enforcement authorities and we will co-operate with those authorities by disclosing your identity to them. In the event of such a breach, your right to use our site will cease immediately.

 

Rules about linking to our site

You may link to our home page, provided you do so in a way that is fair and legal and does not damage our reputation or take advantage of it.

 

You must not establish a link in such a way as to suggest any form of association, approval or endorsement on our part where none exists.

 

You must not establish a link to our site in any website that is not owned by you.

 

Our site must not be framed on any other site, nor may you create a link to any part of our site other than the home page.

 

We reserve the right to withdraw linking permission without notice.

 

If you wish to link to or make any use of content on our site other than that set out above, please contact:

 

Which country’s laws apply to any disputes?

These terms of use, their subject matter and their formation (and any non-contractual disputes or claims) are governed by English law. We both agree to the exclusive jurisdiction of the courts of England and Wales.

 

Our trade marks are registered

Unless otherwise indicated, all our product names are registered trademarks. All our logos and trademarks may not be used or reproduced without our prior written consent, unless they are part of material you are using as permitted under How you may use material on our site set out above.

 

We may make changes to these terms

We amend these terms from time to time. Every time you wish to use our site, please check these terms to ensure you understand the terms that apply at that time.

 

We may make changes to our site

We may update and change our site from time to time.

 

We may suspend or withdraw our site

Our site is made available free of charge.

 

We do not guarantee that our site, or any content on it, will always be available or be uninterrupted. We may suspend or withdraw or restrict the availability of all or any part of our site for business and operational reasons. We will try to give you reasonable notice of any suspension or withdrawal.

 

You are also responsible for ensuring that all persons who access our site through your internet connection are aware of these terms of use and other applicable terms and conditions, and that they comply with them.

 

There are other terms and policies that may apply to you

 

These refer to the following additional terms and policies, which also apply to your use of our site:

 

Our Privacy Policy sets out the terms on which we process any personal data we collect from you, or that you provide to us. By using our site, you consent to such processing and you warrant that all data provided by you is accurate.

 

Our Cookie Policy, which sets out information about the cookies on our site.

 

Contact us

In case of any questions/queries, you may contact us via email at or by post at Recordati UK Ltd and Recordati Rare Diseases UK Ltd and, Breakspear Park, Breakspear Way, Hemel Hempstead, Hertfordshire, HP2 4TZ.

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to support.microsoft.com

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to clinicaltrials.gov

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to hpra.ie

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to yellowcard.mhra.gov.uk

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to search.disclosureuk.org.uk

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to support.apple.com

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to support.mozilla.org

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to support.google.com

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to youronlinechoices.com

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to edpb.europa.eu

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to edoeb.admin.ch

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to ico.org.uk

ACCEPT
GO BACK

Leaving recordatirarediseases.co.uk

You are now leaving this site, a corporate Recordati Rare Diseases website, and are being redirected to careers.recordati.com

ACCEPT
GO BACK
Recordati for the planet
A clean environment is essential for people’s well-being: the health of the planet and the health of people is tightly interconnected. Environmental elements, such as air, water, land and climate, all have an impact on the well-being of humans. Placing a focus on people’s health and being sustainable therefore also means prioritising environmental protection and a responsibility towards future generations. This is why the Group ensures that it conducts business in a socially responsible manner and in accordance with sustainable practices, national and international laws, and the expectations of stakeholders.
Recordati for the community
We believe that contributing to the well-being of the community and dedicating part of our resources to acts of solidarity is not merely the fulfilment of company obligations or professional duty, but rather a moral imperative, an essential part of a healthy business capable of growth but at the same time able to support and develop the community in which it operates and make its employees proud.
Value and diversity of our people
At Recordati, we believe in equal opportunities and we guarantee that everyone can achieve their potential. We see diversity as a value and will not tolerate any discrimination based on ethnicity, nationality, gender, sexual orientation, disability, age, political or religious belief, or any other personal characteristics. At Recordati, we work hard to create a safe and inclusive work environment, where we all have our rights to physical and psychological integrity respected on a daily basis, as well as our right to freedom of opinion and association. We recognise that we each have a role to play in the success of our business and we implement staff development policies through which everyone’s contribution and achievements can be appropriately rewarded.
Multiple opportunities
Recordati is uniquely structured to bring treatment options across specialty and primary care, consumer healthcare, and rare diseases. We have fully integrated operations across research and development, chemical and finished product manufacturing through to commercialisation and licensing.
Luigi Longinotti
Managing Director and General Manager EMEA

Luigi Longinotti is Managing Director and General Manager for EMEA at Recordati Rare Diseases, leading the European and Middle Eastern Commercial Operations. He is responsible for Marketing, Medical, Market Access, Regulatory, Manufacturing and Logistics, as well as the enabling functions to support the business, including Compliance and Quality.

 

He joined Recordati in July 2014 as Corporate Portfolio Management Director for Orphan Drugs. In such a role he has been responsible for driving the growth of the rare disease portfolio at Recordati, with his duties ranging from business development to strategic marketing and pipeline project management.

 

Before he joined Recordati, he held senior business and corporate development roles at Chiesi Farmaceutici and Menarini Group where he executed several key asset deals and transactions.

Luigi gained a degree in Economics from the University of Florence and a Master’s degree in Business Innovation from Sant’Anna School of Advanced Studies in Pisa.

Bruno Parenti
Head of LAC Region, Head of Global Endocrinology Franchise

Bruno Parenti is Head of LAC Region at Recordati Rare Diseases, leading the business in Latin America, Asia Pacific and Russia. He has been in this position since 2011, where he spearheaded the expansion of operations around the globe. He recently assumed the additional role of Head of Global Endocrinology Franchise, establishing the new HQ in Basel and building a dedicated organization.

 

Prior to these positions, Bruno spent two years at Recordati Ireland overseeing international sales in the Asia-Pacific region. He served at Chiesi Farmaceutici for two years as Area Manager for the Far East. Earlier in his career, he held commercial roles at Kedrion Biopharmaceuticals where he was responsible for international markets with a focus on Latin America and the Middle East.

Mohamed Ladha
President and General Manager, North America

Mohamed Ladha is the President and General Manager at Recordati Rare Diseases where he is   responsible for the US and Canadian business. During his career,  Mohamed has held numerous leadership positions globally in hematology/oncology and specialty care to oversee business in the US, Canada, EU, China, Emerging Markets, and Japan.

 

Mohamed  joins Recordati Rare Diseases from Oncopeptides, where he was the General Manager and Executive Vice President for the US Region Business Unit. Prior to Oncopeptides, he served in a series of leadership positions of increasing responsibility at companies including Vertex Pharmaceuticals, Pfizer, Schering-Plough, Merck & Company, Hospira, ARIAD Pharmaceuticals, Takeda Oncology, and Tocagen. He started his career in basic science research focused in oncology at the Dana-Farber Cancer Institute.

 

Mohamed graduated from Hampshire College with a Bachelor of Arts degree. He also holds professional/graduate degrees from Harvard University’s Kennedy School of Government and Northwestern University’s Kellogg School of Management.

 

Changing to first name to be consistent with bio below, also feel that first name as opposed to Mr has a more informal and friendly tone.   [EC1]

Scott Pescatore
Executive Vice President

Scott Pescatore is Vice President and Head of Global Operations at Recordati Rare Diseases.

He holds a Doctor of Pharmacy degree and completed his post-doctoral fellowship in Pharmacology and Drug Development. Dr Pescatore has spent over 20 years working internationally in the pharmaceutical industry, specializing in oncology, haematology and rare diseases.

 

He joined Novartis Oncology US in 2001 where he served in various medical, sales and marketing roles of increasing responsibility. In 2008, he moved to Novartis Oncology UK as Business Franchise Head for solid tumours where he also managed the New Products portfolio. In 2010 he moved to Milan to manage the Region Europe Haematology Franchise where he led the joint venture between Novartis Oncology and Incyte to launch a novel treatment for myeloproliferative disorders. In 2014 he was appointed the Oncology General Manager in Ireland and after three years returned to Milan as General Manager of the Region Europe Rare Disease Business Unit, overseeing operations in 37 markets and focusing on the endocrinology portfolio.

 

Prior to joining Recordati Rare Diseases in 2020, he was Vice President Oncology Business Unit for AstraZeneca Italy where he was responsible for the portfolio of oncology/haematology products including two joint ventures with MSD and Daiichi Sankyo.

You are about to leave this site and visit the recordati global website?

To continue please click the link below.

Visit Global Site